Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05Valérie Boige, Pierre Laurent‐Puig, David Malka et al.|Journal of Clinical Oncology|2010Cited by 169